Live Breaking News & Updates on Supporters of the national coalition party

Stay informed with the latest breaking news from Supporters of the national coalition party on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Supporters of the national coalition party and stay connected to the pulse of your community

Survey: 55% in Finland say they'll 'definitely' vote in EU elections — and that's an improvement

Survey: 55% in Finland say they'll 'definitely' vote in EU elections — and that's an improvement
yle.fi - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yle.fi Daily Mail and Mail on Sunday newspapers.

Finland , Finns-party-or-christian-democrats , Supporters-of-the-national-coalition-party , Finns-party , European-union , News-media , Christian-democrats , National-coalition-party ,

Morning headlines: Tuesday 22nd December 2020

Government to approve vaccines decree, as first batch arrives
Government ministers are set to meet in a special session on Tuesday to approve a decree that will allow Covid-19 vaccinations to begin in Finland. European regulators have approved a marketing authorisation for the first vaccine, from Pfizer-BioNtech, so that a rollout programme can begin. The initial batches of the vaccine, which must be stored at ultra-low temperatures, are also expected to arrive in Finland this week and vaccinations will begin on 27th December, authorities say. Clinical studies show that the vaccine is about 95% effective, meaning that the number of laboratory-confirmed cases of Covid-19 was reduced by 95% in people who received the vaccine compared with those who received the placebo. The vaccine also proved effective in at-risk groups such as people with asthma, chronic lung disease, diabetes, hypertension or who are overweight. The vaccine is given in two doses, with 21 days between vaccinations. According to THL most of the side effects of the vaccine are mild and transient, such as reactions at the injection site such as redness and swelling; as well as fever, headache, muscle and joint pain.

Northern-ostrobothnia , Finland , United-kingdom , Laajasalo , Uusimaa-region , Helsinki , Eteläuomen-läi , Manchester , North-karelia , London , City-of , Edinburgh